[HTML][HTML] Pharmacotherapy of anxiety disorders: current and emerging treatment options

A Garakani, JW Murrough, RC Freire, RP Thom… - Frontiers in …, 2020 - frontiersin.org
Anxiety disorders are the most prevalent psychiatric disorders and a leading cause of
disability. While there continues to be expansive research in posttraumatic stress disorder …

Using neuroscience to help understand fear and anxiety: a two-system framework

JE LeDoux, DS Pine - American journal of psychiatry, 2016 - Am Psychiatric Assoc
Tremendous progress has been made in basic neuroscience in recent decades. One area
that has been especially successful is research on how the brain detects and responds to …

Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders

MA Katzman, P Bleau, P Blier, P Chokka, K Kjernisted… - BMC psychiatry, 2014 - Springer
Background Anxiety and related disorders are among the most common mental disorders,
with lifetime prevalence reportedly as high as 31%. Unfortunately, anxiety disorders are …

Hormonal treatments for major depressive disorder: state of the art

JB Dwyer, A Aftab, R Radhakrishnan… - American Journal of …, 2020 - Am Psychiatric Assoc
Major depressive disorder is a common psychiatric disorder associated with marked
suffering, morbidity, mortality, and cost. The World Health Organization projects that by 2030 …

The corticotropin-releasing factor family: physiology of the stress response

JM Deussing, A Chen - Physiological reviews, 2018 - journals.physiology.org
The physiological stress response is responsible for the maintenance of homeostasis in the
presence of real or perceived challenges. In this function, the brain activates adaptive …

Time to connect: bringing social context into addiction neuroscience

M Heilig, DH Epstein, MA Nader… - Evaluating the Brain …, 2022 - taylorfrancis.com
Research on the neural substrates of drug reward, withdrawal and relapse has yet to be
translated into significant advances in the treatment of addiction. One potential reason is that …

Emerging drugs for the treatment of anxiety

JW Murrough, S Yaqubi, S Sayed… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: Anxiety disorders are among the most prevalent and disabling psychiatric
disorders in the United States and worldwide. Basic research has provided critical insights …

The age of anxiety: role of animal models of anxiolytic action in drug discovery

JF Cryan, FF Sweeney - British journal of pharmacology, 2011 - Wiley Online Library
Anxiety disorders are common, serious and a growing health problem worldwide. However,
the causative factors, aetiology and underlying mechanisms of anxiety disorders, as for most …

Don't stress about CRF: assessing the translational failures of CRF1antagonists

SR Spierling, EP Zorrilla - Psychopharmacology, 2017 - Springer
Abstract Background Dr. Athina Markou sought treatments for a common neural substrate
shared by depression and drug dependence. Antagonists of corticotropin-releasing factor …

Pharmacogenetic approaches to the treatment of alcohol addiction

M Heilig, D Goldman, W Berrettini… - Nature Reviews …, 2011 - nature.com
Addictive disorders are partly heritable, chronic, relapsing conditions that account for a
tremendous disease burden. Currently available addiction pharmacotherapies are only …